Monday, April 9, 2018

FDA worried drug was risky; now reports of deaths spark concern
Doctors and other experts tell CNN they worried that a new drug, Nuplazid, aimed at treating Parkinson's disease patients with hallucinations was approved too quickly. Now hundreds of reports of deaths are raising more red flags. Read the full story

No comments: